// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Review of initial management of giant cell arteritis prior to assessment by a rheumatologist

Farnaz Bhad - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

Glucocorticoid

The introduction of a new EIA service in a busy urban hospital

Marius R Theiveehathasan - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Rheumatology helpline: an increasing workload but maintaining patient satisfaction

Elaine Wren - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What’s in a name? Quite a lot when it comes to rheumatology diagnoses?

Kathryn Biddle - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

The impact of hypogammaglobulinaemia with rituximab treatment

Suchi A Ghosh - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Microscopic polyangiitis

Rituximab

Small, pilot study shows that video-based training in button-free auto-injection does not impair user confidence, competence or satisfaction with methotrexate injection

Dawn Homer - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methotrexate

Etanercept (ETN) biosimilar (Benapali - SB4) switches in inflammatory arthritis patients at Wrightington Hospital

Perpetual C Uke - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Etanercept biosimilar

Evaluating the need for an acute rheumatology referral service

Randa Alshakh - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ESR or CRP - Which should it be? a study of inflammatory marker requests

Laura To - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Virtual biologic clinic: the key component at Royal Free Hospital

Titi Peleyeju - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Assessing the reliability of self-reported questionnaires in the context of healthcare utilisation in inflammatory arthritis

Jessica C Tromans - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Group education for patients prior to biologic and targeted synthetic disease modifying anti-rheumatic drugs: a quality improvement project at The Dudley Group NHSFT

Rameez Arif - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Audit of hydroxychloroquine retinopathy screening within rheumatology services at UCLH

Amy MacBrayne - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Hydroxychloroquine

Patient experience of switching to biosimilar Benepali

Nadia Ahmad - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Etanercept biosimilar

TB or not TB? The experience in a large urban district general hospital rheumatology department

Alice Parle - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An audit comparing the application of urate lowering therapy in a primary care setting against guidelines from the British Society for Rheumatology

Logan Sun - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Renal insufficiency

N/A

Odd numbers: what happens in rheumatology follow-up clinics?

Rebecca Saveker - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

National survey to evaluate current practice of initiating and monitoring hydroxychloroquine in secondary care

Shilpa Jagadeesh - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Practical implementation of NICE guidance 65 for spondyloarthritis as a service improvement for care of axial spondyloarthritis

Antoni Chan - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Patient experience of switching from Enbrel to Benapali

Sandra Robinson - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Etanercept

Copyright © 2026. QuantiNova All rights reserved